Prognosis of Patients with Hepatocellular Carcinoma Treated Solely with Transcatheter Arterial Chemoembolization: Risk Factors for One-year Recurrence and Two-year Mortality (Preliminary Data)-Reference-Cited by-同舟云学术

Prognosis of Patients with Hepatocellular Carcinoma Treated Solely with Transcatheter Arterial Chemoembolization: Risk Factors for One-year Recurrence and Two-year Mortality (Preliminary Data)

Published:2013 Issue:8 Volume:52 Page:847-853
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Matsuda Michitaka¹,Omata Fumio¹,Fuwa Sokun²,Saida Yukihisa²,Suzuki Shoko¹,Uemura Masayo¹,Ishii Naoki¹,Iizuka Yusuke¹,Fukuda Katsuyuki¹,Fujita Yoshiyuki¹

Affiliation:

1. Department of Internal Medicine, St. Luke's International Hospital, Japan

2. Department of Radiology, St. Luke's International Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/52/8/52_52.9356/_pdf

Reference21 articles.

1. 1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.

2. 2. Qiu D, Katanoda K, Marugame T, Sobue T. A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004). Int J Cancer 124: 443-448, 2009.

3. 3. Umemura T, Ichijo T, Yoshizawa K, Tanaka E, Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. J Gastroenterol 44 Suppl 19: 102-107, 2009.

4. 4. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2: 533-554, 2001.

5. 5. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359: 1164-1171, 2002.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gadoxetic Acid-Enhanced MRI Features for Predicting Treatment Outcomes of Early Hepatocellular Carcinoma (< 3 cm) After Transarterial Chemoembolization;Academic Radiology;2022-09

2. Association of Sustained Response Duration With Survival After Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma;JAMA Network Open;2018-10-05

3. Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization;Oncology Letters;2017-06-28

4. Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan;Clinical Therapeutics;2017-04

5. Effects of combining transarterial chemoembolization with percutaneous microwave coagulation therapy for hepatocellular carcinoma abutting the diaphragm;Minimally Invasive Therapy & Allied Technologies;2015-11-11